Chicago Illinois,
CLINICAL EVENTS CALENDAR
- StartJul 15,2010EndJul 17,2010Third Annual Cardiovascular Interventions: Head-to-Toe Meeting: Napa Valley, CAhttp://www.h2tmeeting.org/
- StartJul 18,2010EndJul 18,2010Super Tech Course for CSI (Diamondback): Hands-on, presented by Orlando Marrero, RCIS, MBA, Winter Haven Hospital, FLOrlando.Marrero@WinterHavenHospital.org
- StartJul 18,2010EndJul 21,2010Pediatric & Adult Interventional Cardiac Symposium With Live Case Demonstrations: Sheraton Hotel & Towers, Chicago, ILhttp://www.picsymposium.com
- StartJul 19,2010EndJul 23,2010Hawaii 2010: Principles and Perspectives in Interventional Cardiologywww.hawaiippic.com
Cath Lab Digest Blogs
So Much Information...
In today’s technical world, it seems every day there is another device, a new drug, or
a recently developed procedure. It is, at times, mind-boggling when you consider the amount of new information and data one needs just to stay knowledgeable and current in the field of cardiology, especially interventional cardiology. When do you find the time or the energy to review recently published articles on trials and various studies that are constantly being done around the world? Even if you find the time, the articles are often very lengthy, and difficult to read and comprehend. All the data numbers, the statistics, the endpoints. You really have to be able to read the information, sift through it all and form an opinion regarding the data presented. What are the drawbacks of the study design that may influence the outcomes found? Were the trials multi-center, randomized and double-blind? Was there enough patient enrollment to be statistically significant?
Case Study of an Alternative Strategy to Achieve Hemostasis in an Oozing From Femoral Procedure Site
We have all seen this scenario before: a 6 Fr closure device used in a 7 Fr hole. Most of the significant bleeding has stopped, but there is still oozing and bleeding noted at the site. The physician says “handhold till it stops.” What about the 7,500 units of heparin, 600mg of clopidogrel, 325mg of aspirin, and the double bolus and drip of eptifibatide? What about “Just put a pressure dressing on it”? There needs to be a better way.
In our department, we have used hemostatic patches and manual compression as the primary topical sealant with post-procedure bleeding. After 10 to 15 minutes of handhold, if the site still is bleeding and no hematoma is noted, an assistive compression device is used. A few of our physicians still write for a pressure dressing to be applied to the site after handhold. Even with all of these measures, we still have one or two patients that require “thinking outside the box” treatments.
Still Using a Contrast Warmer?
I get questions from colleagues around the country on a fairly regular basis. Every once in a while, there is a recurrent theme. Most recently, I have had questions related to the use of contrast media warmers.
Back in late 2006/early 2007, our pharmacy department received warnings/recommendations regarding noncompliance with contrast warmers — both during a Mock Survey conducted by the Joint Commission consultant and during a medication management consultation by a Joint Commission consultant. Contrast media are considered medications, and as such, their storage and use must comply with all of the medication management standards.
"That's the Way We've Always Done It"
I think there is no other string of words put together that incites more frustration in the work environment. When someone is questioned as to why we do something a specific way and they respond, "That's the way we've always done it," it immediately invokes a few presuppositions in my mind. The person being questioned either: 1) Could care less about helping others learn and gain understanding; 2) Hasn't got a clue why it is done that way (and are unwilling to admit it); 3) Is so closed-minded they are unwilling to accept there may be a better, easier or at least equal way of doing it; or 4) Feels threatened if someone else "knows" as much as them — fearing for their job, status or whatever (the only reason one should have those fears is if they sit on their laurels and have stopped learning and pursuing excellence).
New Regulations on Radiation Exposure to Patients Heading Our Way
Recent articles in Cardiology Today as well as the U.S. Department of Health & Human Services made reference to an initiative proposed by the Food and Drug Administration to reduce the radiation exposure patients receive from medical imaging.(1-2) An article in the San Diego Union-Tribune on February 17, 2010, stated, “The use of high-tech diagnostic imaging in emergency rooms has quadrupled since the mid-1990’s. The frequency of the medical scans nearly tripled at doctor offices and outpatient clinics.”(3) The FDA sees the benefits medical imaging has resulted in, such as early diagnosis and treatments, but is concerned about the risks involved.
A Refresher on Pressure
Click to Enlarge Images
In the era of vascular closure devices, the skill of achieving hemostasis by manual compression is almost becoming a lost art. It concerns me to see cath lab personnel that do not have a good technique for manual compression. When those closure devices fail, we need to be confident in our ability to manage hemostasis. Most seem to go with the "brute force" or "monster mash" technique. While this can be effective, it presents some concerns.
First, a "brute force" or "monster mash" technique is more uncomfortable for the patient. Second, it tends to cause more bruising and displaces the skin is a way that makes it difficult to assess if a hematoma is developing. Third, this technique is often not effective in our "well nourished" patients (specifically those with a tight, round belly). Finally, it is physically more demanding on the staff and often leads to the excuse "I'm just not strong enough to hold pressure," requiring calling upon your second hand to assist.
Prasugrel…The New Kid on the Block!
In July 2009, the FDA approved the drug prasugrel (Effient) in the treatment of acute coronary syndrome patients who had planned percutaneous coronary intervention. Prasugrel, in clinical trials, has been associated with a decrease in ischemic events (including stent thrombosis), but also an increase in the risk of bleeding, including fatal bleeding.1 One study showed that when compared to clopidogrel (Plavix), prasugrel had greater platelet inhibition. This study looked at patients receiving 60 mg prasugrel compared to clopidogrel 600 mg po as a loading dose, and also on maintenance doses of
My First Blog: An Introduction
Hello, everyone. This is my first-ever attempt at blogging. So, as I move into a new arena of technology…ok, I know, you all are saying “Hey, Jon, welcome to 1997, the year the first blog was recorded.” Well, blame it on work schedule or being part of a family with 3 boys. I just haven’t had the time or know-how to participate in what some consider everyday life. I’m still trying to figure out Facebook. (Is that confusing to anyone else?)
I wanted to write my first blog as an introduction, but on a monthly basis, I will be blogging things related to cath lab life, education, rese
A Cost-Cutting Forum
We in the cath lab have many challenges ahead with all the healthcare insurance changes facing us.
We must begin to think outside the box for ways to lower our cost of providing high quality healthcare, as well as to create a database of where every penny goes.
For instance, here’s one thought, involving the creation of a private buying group. We poll all interested parties to find out which widgets everyone buys and at what cost they buy the widgets for — then our buying group bulk buys these widgets at the lowest costs possible (much like Walmart).
The group 'member' then buy
Transradial vs. Femoral Access
Transradial coronary angiography and PCI seems to be everywhere these days. Pick up a cardiac journal, visit various cath-related websites, and you cannot escape being inundated with industry ads, articles on technique, and workshops offered at various conferences.
Data from the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) shows that currently, radial access is extremely rare in United States practice (1.32% of procedures done through the radial artery). However, in many European countries (such as France, Italy, and Spain) radial access is not only comm
Is Your Lab Using the SYNTAX Score?
Several trials have been conducted comparing coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) in patients with multi-vessel disease (MVD). CABG has done better mainly because there is a higher rate of revascularization in the percutaneous intervention arm of the studies. One recurring criticism has been that there was no measurable way to take into account the severity or complexity of the CAD. Obviously a patient with left main disease involving the ostium of the left anterior descending artery (LAD) and circumflex is a higher risk than a patient with mi
Breaking News
Cath Lab Surveys
Center for Education & Practice Development - Learning Module Femoral Artery Sheath Management(PDF) This learning module is designed for the Registered Nurse Division 1 working in areas where
patients are undergoing percutaneous cardiac catheterisation and interventions.
Cath Lab Digest Blogs
- Seiji E. Kashiwabara, RN, NREMT-P
All Subscriptions are FREE to qualified cardiology professionals

- Subscribe to:
- Journal
- Digital Journal
- E-News
- RSS feed






















